Pediatric Pharmacokinetics Human Development and Drug Disposition

被引:35
|
作者
Funk, Ryan S. [1 ]
Brown, Jacob T. [1 ]
Abdel-Rahman, Susan M. [1 ,2 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Med Toxicol, Kansas City, MO 64108 USA
[2] Univ Missouri, Dept Pediat, Sch Med, Kansas City, MO 64108 USA
关键词
Pediatric; Pharmacokinetic; Development; Absorption; Distribution; Metabolism; Excretion; Transport; SINGLE-DOSE PHARMACOKINETICS; PLASMA-PROTEIN BINDING; AGE-RELATED-CHANGES; TISSUE DISTRIBUTION; HUMAN LIVER; POPULATION PHARMACOKINETICS; INTRAVENOUS OMEPRAZOLE; HEALTHY-VOLUNTEERS; PRETERM INFANTS; SMALL-INTESTINE;
D O I
10.1016/j.pcl.2012.07.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Human development is described by the various anatomic and physiologic changes that occur as the single-celled zygote matures into an adult human being. Concomitant with bodily maturation are changes in the complex interactions between pharmacologic agents and the biologic matrix that is the human body. Profound changes in the manner by which drugs traverse the body during development can have significant implications in drug efficacy and toxicity. Although not a replacement for well-conducted, pediatric, pharmacokinetic studies, an understanding of developmental biology and the mechanisms for drug disposition invariably assists the pediatric clinician with the judicious use of medications in children.
引用
收藏
页码:1001 / +
页数:17
相关论文
共 50 条
  • [31] The role of gut microbial β-glucuronidase in drug disposition and development
    Gao, Song
    Sun, Rongjin
    Singh, Rashim
    So, Sik Yu
    Chan, Clement T. Y.
    Savidge, Tor
    Hu, Ming
    DRUG DISCOVERY TODAY, 2022, 27 (10)
  • [32] Absorption, Disposition and Pharmacokinetics of Nanoemulsions
    Lu, Yi
    Qi, Jianping
    Wu, Wei
    CURRENT DRUG METABOLISM, 2012, 13 (04) : 396 - 417
  • [33] THE PHARMACOKINETICS AND DISPOSITION OF IBUPROFEN IN THE CAMEL
    Wasfi, I. A.
    Elghazali, M.
    Eltayeb, F. M.
    Hadi, A. A. Abdel
    JOURNAL OF CAMEL PRACTICE AND RESEARCH, 2010, 17 (02) : 257 - 262
  • [34] Physicochemistry of Cereblon Modulating Drugs Determines Pharmacokinetics and Disposition
    Kong, Nikki R.
    Liu, Hu
    Che, Jianwei
    Jones, Lyn H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (11): : 1861 - 1865
  • [35] Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs
    Sjogren, Erik
    Hedeland, Mikael
    Bondesson, Ulf
    Lennernas, Hans
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 57 : 214 - 223
  • [36] Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
    Temrikar, Zaid H.
    Suryawanshi, Satyendra
    Meibohm, Bernd
    PEDIATRIC DRUGS, 2020, 22 (02) : 199 - 216
  • [37] Neonatal Development of Hepatic UGT1A9: Implications of Pediatric Pharmacokinetics
    Miyagi, Shogo J.
    Milne, Alison M.
    Coughtrie, Michael W. H.
    Collier, Abby C.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (07) : 1321 - 1327
  • [38] Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug
    Song, Wei
    Liu, Meilin
    Wu, Junjun
    Zhai, Hong
    Chen, Yong
    Peng, Zhihong
    CURRENT DRUG METABOLISM, 2019, 20 (02) : 147 - 154
  • [39] Bedaquiline: a review of human pharmacokinetics and drug-drug interactions
    van Heeswijk, R. P. G.
    Dannemann, B.
    Hoetelmans, R. M. W.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2310 - 2318
  • [40] Kinetic aspects of drug disposition in the lungs
    Upton, RN
    Doolette, DJ
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (5-6) : 381 - 391